BioCentury | Jun 1, 2019
Product Development
ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts
While strong progress in CAR T therapies will again feature at this year’s ASCO meeting, bispecific antibodies are having a moment -- making more inroads into solid tumors than CAR Ts and branching out via...